Schmidt S, Wichers-Misterek J, Behrens H, Birnbaum J, Henshall I, Droge J
PLoS Pathog. 2023; 19(12):e1011814.
PMID: 38039338
PMC: 10718435.
DOI: 10.1371/journal.ppat.1011814.
Guan H, Wang P, Zhang P, Ruan C, Ou Y, Peng B
Nature. 2023; 620(7974):669-675.
PMID: 37468628
PMC: 10432269.
DOI: 10.1038/s41586-023-06349-1.
Guo Z, Chu C, Lu Y, Zhang X, Xiao Y, Wu M
Nat Struct Mol Biol. 2023; 30(6):753-760.
PMID: 37081318
DOI: 10.1038/s41594-023-00975-z.
Wang C, Guo Z, Chu C, Lu Y, Zhang X, Zhan X
Cell Discov. 2023; 9(1):42.
PMID: 37076472
PMC: 10115800.
DOI: 10.1038/s41421-023-00539-x.
Lettow J, Kliewe F, Aref R, Schuller H
Curr Genet. 2023; 69(2-3):127-139.
PMID: 36854981
PMC: 10163088.
DOI: 10.1007/s00294-023-01262-6.
Systematic identification and characterization of repressive domains in Drosophila transcription factors.
Klaus L, de Almeida B, Vlasova A, Nemcko F, Schleiffer A, Bergauer K
EMBO J. 2022; 42(3):e112100.
PMID: 36545802
PMC: 9890238.
DOI: 10.15252/embj.2022112100.
Structural Insight into the Binding of TGIF1 to SIN3A PAH2 Domain through a C-Terminal Amphipathic Helix.
He X, Nie Y, Zhou H, Hu R, Li Y, He T
Int J Mol Sci. 2021; 22(23).
PMID: 34884456
PMC: 8657803.
DOI: 10.3390/ijms222312631.
αα-Hub domains and intrinsically disordered proteins: A decisive combo.
Bugge K, Staby L, Salladini E, Falbe-Hansen R, Kragelund B, Skriver K
J Biol Chem. 2020; 296:100226.
PMID: 33361159
PMC: 7948954.
DOI: 10.1074/jbc.REV120.012928.
Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy.
Verza F, Das U, Fachin A, Dimmock J, Marins M
Cancers (Basel). 2020; 12(6).
PMID: 32585896
PMC: 7352721.
DOI: 10.3390/cancers12061664.
SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations.
Takedachi A, Despras E, Scaglione S, Guerois R, Guervilly J, Blin M
Nat Struct Mol Biol. 2020; 27(5):438-449.
PMID: 32398829
DOI: 10.1038/s41594-020-0419-3.
The neuronal transcription factor Myt1L interacts via a conserved motif with the PAH1 domain of Sin3 to recruit the Sin3L/Rpd3L histone deacetylase complex.
Marcum R, Radhakrishnan I
FEBS Lett. 2020; 594(14):2322-2330.
PMID: 32391601
PMC: 8224932.
DOI: 10.1002/1873-3468.13811.
An MXD1-derived repressor peptide identifies noncoding mediators of MYC-driven cell proliferation.
Raffeiner P, Hart J, Garcia-Caballero D, Bar-Peled L, Weinberg M, Vogt P
Proc Natl Acad Sci U S A. 2020; 117(12):6571-6579.
PMID: 32156728
PMC: 7104257.
DOI: 10.1073/pnas.1921786117.
Co-repressor, co-activator and general transcription factor: the many faces of the Sin3 histone deacetylase (HDAC) complex.
Adams G, Chandru A, Cowley S
Biochem J. 2018; 475(24):3921-3932.
PMID: 30552170
PMC: 6295471.
DOI: 10.1042/BCJ20170314.
Sin3A recruits Tet1 to the PAH1 domain via a highly conserved Sin3-Interaction Domain.
Chandru A, Bate N, Vuister G, Cowley S
Sci Rep. 2018; 8(1):14689.
PMID: 30279502
PMC: 6168491.
DOI: 10.1038/s41598-018-32942-w.
The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis.
Carroll P, Freie B, Mathsyaraja H, Eisenman R
Front Med. 2018; 12(4):412-425.
PMID: 30054853
PMC: 7358075.
DOI: 10.1007/s11684-018-0650-z.
Sin3a-Tet1 interaction activates gene transcription and is required for embryonic stem cell pluripotency.
Zhu F, Zhu Q, Ye D, Zhang Q, Yang Y, Guo X
Nucleic Acids Res. 2018; 46(12):6026-6040.
PMID: 29733394
PMC: 6158608.
DOI: 10.1093/nar/gky347.
The potential of targeting Sin3B and its associated complexes for cancer therapy.
Cantor D, David G
Expert Opin Ther Targets. 2017; 21(11):1051-1061.
PMID: 28956957
PMC: 5679076.
DOI: 10.1080/14728222.2017.1386655.
Mrhl Long Noncoding RNA Mediates Meiotic Commitment of Mouse Spermatogonial Cells by Regulating Sox8 Expression.
Kataruka S, Akhade V, Kayyar B, Satyanarayana Rao M
Mol Cell Biol. 2017; 37(14).
PMID: 28461394
PMC: 5492173.
DOI: 10.1128/MCB.00632-16.
Suppression of Sin3A activity promotes differentiation of pluripotent cells into functional neurons.
Halder D, Lee C, Hyun J, Chang G, Cheong E, Shin I
Sci Rep. 2017; 7:44818.
PMID: 28303954
PMC: 5356016.
DOI: 10.1038/srep44818.
Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.
Kwon Y, Petrie K, Leibovitch B, Zeng L, Mezei M, Howell L
Mol Cancer Ther. 2015; 14(8):1824-36.
PMID: 26078298
PMC: 4529816.
DOI: 10.1158/1535-7163.MCT-14-0980-T.